Tech Company Financing Transactions
Pierrepont Therapeutics Funding Round
Pierrepont Therapeutics closed a $500 thousand investment round on 4/8/2024. Backers included The Mito Fund.
Transaction Overview
Company Name
Announced On
4/8/2024
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D sector.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
Pittsburgh, PA Undisclosed
USA
Pittsburgh, PA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Pierrepont Therapeutics is dedicated to developing targeted treatments for primary mitochondrial diseases. The founders of Pierrepont have unique expertise and success in mitochondrial disease drug development, and have strong relationships with KOLs, families and patient advocacy groups in the mitochondrial disease community.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Daniel DiPietro
Browse more venture capital transactions:
Prev: 4/8/2024: Leash Biosciences venture capital transaction
Next: 4/8/2024: CLLCT venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs